Pharmaceutical Industry Trends & News - Pharmaceutical Technology

News

BMS and Oxford BioTherapeutics join forces in TCE discovery pact

This partnership meshes with OBT’s hybrid partnership-pipeline strategy, which prioritises collaboration to extend its market impact.

Annabel Kartal Allen

Comment

Advancing single-cell transcriptomics into the mainstream of biomedical research

News

Roche and C4 Therapeutics to advance degrader-antibody conjugates research

Salong Debbarma

Partner Content

Precision Medicine in Early Oncology Trials: Biomarkers as Strategic Drivers

News

FDA seeks permanent future for rare pediatric priority review vouchers

News

EverSea Medicines to acquire Hasten Biopharmaceuticals

News

Gan & Lee and JW Pharmaceutical agree on bofanglutide commercialisation

News

Shionogi secures $482m BARDA contract to tackle AMR crisis

Analysis

Analyst Comment

Emerging therapies bring hope for frail HNSCC patients unfit for standard treatment

GlobalData Healthcare

Analyst Comment

In the face of tariffs, FDA-approved drug manufacturing deals are shifting to Europe

GlobalData Healthcare

Analyst Comment

HNSCC market is expected to reach to $4.5bn across 8MM by 2034

GlobalData Healthcare

Analyst Comment

ACC 2026: sotatercept meta-analysis backs disease-modifying role in PAH

GlobalData Healthcare

Themes

Partner Content

CinnaGen Enters EU Market with EMA Approval for Zandoriah®

CinnaGen today announced that the European Medicines Agency (EMA) has adopted a positive opinion recommending the approval of Zandoriah® (teriparatide),…

More themes

News

Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer

Partner Content

Huawei’s three key steps to drive industrial intelligence forward and unleash AI’s full potential

Analyst Comment

First responders see AI and other advanced tech as essential

Features

What does the EU Data Act mean for businesses?

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Bio/Pharmaceutical Outsourcing Report, March 2026

$2950.00

Human Immunodeficiency Virus (HIV) Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033

$17995.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

Advancing single-cell transcriptomics into the mainstream of biomedical research

Roche and C4 Therapeutics to advance degrader-antibody conjugates research

Precision Medicine in Early Oncology Trials: Biomarkers as Strategic Drivers

FDA seeks permanent future for rare pediatric priority review vouchers

EverSea Medicines to acquire Hasten Biopharmaceuticals

Gan & Lee and JW Pharmaceutical agree on bofanglutide commercialisation

Shionogi secures $482m BARDA contract to tackle AMR crisis

Emerging therapies bring hope for frail HNSCC patients unfit for standard treatment

In the face of tariffs, FDA-approved drug manufacturing deals are shifting to Europe

HNSCC market is expected to reach to $4.5bn across 8MM by 2034

ACC 2026: sotatercept meta-analysis backs disease-modifying role in PAH

CinnaGen Enters EU Market with EMA Approval for Zandoriah®

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Bio/Pharmaceutical Outsourcing Report, March 2026

Human Immunodeficiency Virus (HIV) Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033

Diffuse Large B-Cell Lymphoma - Global Clinical Trials Review, 2026

Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, 2026

Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Bio/Pharmaceutical Outsourcing Report, March 2026

Human Immunodeficiency Virus (HIV) Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033

Diffuse Large B-Cell Lymphoma - Global Clinical Trials Review, 2026

Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, 2026

Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing